Curis reported $-13294000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Amgen AMGN:US USD 2.54B 364M
AstraZeneca AZN:LN USD 3.09B 52M
Chimerix CMRX:US USD 241.52M 264.98M
Curis CRIS:US USD -13294000 2.65M
Exelixis EXEL:US USD 92.04M 3.53M
GlaxoSmithKline GSK:LN GBP 1.36B 1.07B
Mirati Therapeutics MRTX:US USD -173307000 3.14M
Novartis NOVN:VX USD 4.06B 72M
Pfizer PFE:US USD 7.38B 3.3B
Roche Holding ROG:VX 12.11B 2.43B
Sanofi SAN:FP EUR 4.43B 1.77B
Spectrum Pharmaceuticals SPPI:US USD -21913000 7.12M
Takeda 4502:JP JPY 107.15B 42.6B
Tg Therapeutics TGTX:US USD -35818000 4.69M
Verastem VSTM:US USD -18090000 3.86M
Xoma XOMA:US USD -4178000 492K
YTE INCY:US USD 178.22M 131.36M